These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37421187)

  • 1. Role of B cells in immune-related adverse events following checkpoint blockade.
    Dhodapkar KM; Duffy A; Dhodapkar MV
    Immunol Rev; 2023 Sep; 318(1):89-95. PubMed ID: 37421187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding adverse events of immunotherapy: A mechanistic perspective.
    Burke KP; Grebinoski S; Sharpe AH; Vignali DAA
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying immune-related adverse events during checkpoint immunotherapy.
    Zhou X; Chen X; Han L; Liu H
    Clin Sci (Lond); 2022 May; 136(10):771-785. PubMed ID: 35621125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma.
    Chuah S; Lee J; Song Y; Kim HD; Wasser M; Kaya NA; Bang K; Lee YJ; Jeon SH; Suthen S; A'Azman S; Gien G; Lim CJ; Chua C; Hazirah SN; Lee HK; Lim JQ; Lim TKH; Yeong J; Chen J; Shin EC; Albani S; Zhai W; Yoo C; Liu H; Choo SP; Tai D; Chew V
    J Hepatol; 2022 Sep; 77(3):683-694. PubMed ID: 35430299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer.
    Piening A; Ebert E; Khojandi N; Alspach E; Teague RM
    Front Immunol; 2022; 13():1022732. PubMed ID: 36582225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity.
    Singh N; Hocking AM; Buckner JH
    Immunol Rev; 2023 Sep; 318(1):81-88. PubMed ID: 37493210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy.
    Kubo T; Hirohashi Y; Tsukahara T; Kanaseki T; Murata K; Morita R; Torigoe T
    Immunol Med; 2022 Jun; 45(2):108-118. PubMed ID: 34542015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity.
    Thanarajasingam U; Abdel-Wahab N
    Rheum Dis Clin North Am; 2020 Aug; 46(3):587-603. PubMed ID: 32631606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.
    Ye W; Olsson-Brown A; Watson RA; Cheung VTF; Morgan RD; Nassiri I; Cooper R; Taylor CA; Akbani U; Brain O; Matin RN; Coupe N; Middleton MR; Coles M; Sacco JJ; Payne MJ; Fairfax BP
    Br J Cancer; 2021 May; 124(10):1661-1669. PubMed ID: 33723392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
    Kumar P; Saini S; Prabhakar BS
    Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
    Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
    J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation.
    Yang H; Yao Z; Zhou X; Zhang W; Zhang X; Zhang F
    Clin Immunol; 2020 Apr; 213():108377. PubMed ID: 32135278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
    Khan S; Gerber DE
    Semin Cancer Biol; 2020 Aug; 64():93-101. PubMed ID: 31330185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight in endocrine-related adverse events associated to immune checkpoint blockade.
    Elia G; Ferrari SM; Galdiero MR; Ragusa F; Paparo SR; Ruffilli I; Varricchi G; Fallahi P; Antonelli A
    Best Pract Res Clin Endocrinol Metab; 2020 Jan; 34(1):101370. PubMed ID: 31983543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-related adverse events in various organs caused by immune checkpoint inhibitors.
    Okiyama N; Tanaka R
    Allergol Int; 2022 Apr; 71(2):169-178. PubMed ID: 35101349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic manifestations of autoimmunity with immune checkpoint inhibitors.
    McCombe JA; Sechi E; Zekeridou A
    Handb Clin Neurol; 2024; 200():449-465. PubMed ID: 38494296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors.
    Weinmann SC; Pisetsky DS
    Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii59-vii67. PubMed ID: 31816080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics
    Wang T; Zheng N; Luo Q; Jiang L; He B; Yuan X; Shen L
    Front Immunol; 2019; 10():1235. PubMed ID: 31214189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine immune-related adverse effects of immune-checkpoint inhibitors.
    Trevisani V; Iughetti L; Lucaccioni L; Predieri B
    Expert Rev Endocrinol Metab; 2023; 18(5):441-451. PubMed ID: 37682107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
    Dougan M; Blidner AG; Choi J; Cooksley T; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Anderson R; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6129-6143. PubMed ID: 32856210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.